Patents by Inventor Lisa Marie Weaver

Lisa Marie Weaver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230232838
    Abstract: Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis.
    Type: Application
    Filed: April 12, 2023
    Publication date: July 27, 2023
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: James A. BAUM, Allen T. CHRISTIAN, Artem EVDOKIMOV, Farhad MOSHIRI, Lisa Marie WEAVER, Haitao ZHANG
  • Patent number: 11647753
    Abstract: Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis.
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: May 16, 2023
    Assignee: Monsanto Technology LLC
    Inventors: James A. Baum, Allen T. Christian, Artem Evdokimov, Farhad Moshiri, Lisa Marie Weaver, Haitao Zhang
  • Patent number: 10757947
    Abstract: Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: September 1, 2020
    Assignee: MONSANTO TECHNOLOGY LLC
    Inventors: James A. Baum, Allen T. Christian, Artem Evdokimov, Farhad Moshiri, Lisa Marie Weaver, Haitao Zhang
  • Publication number: 20190380348
    Abstract: Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis.
    Type: Application
    Filed: June 7, 2019
    Publication date: December 19, 2019
    Applicant: Monsanto Technology LLC
    Inventors: James A. BAUM, Allen T. CHRISTIAN, Artem EVDOKIMOV, Farhad MOSHIRI, Lisa Marie WEAVER, Haitao ZHANG
  • Patent number: 10334858
    Abstract: Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: July 2, 2019
    Inventors: James A. Baum, Allen T. Christian, Artem Evdokimov, Farhad Moshiri, Lisa Marie Weaver, Haitao Zhang
  • Publication number: 20190000089
    Abstract: Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis.
    Type: Application
    Filed: August 14, 2018
    Publication date: January 3, 2019
    Applicant: Monsanto Technology LLC
    Inventors: James A. Baum, Allen T. Christian, Artem Evdokimov, Farhad Moshiri, Lisa Marie Weaver, Haitao Zhang
  • Patent number: 10070652
    Abstract: Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: September 11, 2018
    Assignee: Monsanto Technology LLC
    Inventors: James A. Baum, Allen T. Christian, Artem Evdokimov, Farhad Moshiri, Lisa Marie Weaver, Haitao Zhang
  • Publication number: 20180092364
    Abstract: Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis.
    Type: Application
    Filed: October 10, 2017
    Publication date: April 5, 2018
    Applicant: Monsanto Technology LLC
    Inventors: James A. BAUM, Allen T. CHRISTIAN, Artem EVDOKIMOV, Farhad MOSHIRI, Lisa Marie WEAVER, Haitao ZHANG
  • Patent number: 9814243
    Abstract: Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: November 14, 2017
    Assignee: MONSANTO TECHNOLOGY LLC
    Inventors: James A. Baum, Allen T. Christian, Artem Evdokimov, Farhad Moshiri, Lisa Marie Weaver, Haitao Zhang
  • Publication number: 20170035056
    Abstract: Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis.
    Type: Application
    Filed: August 15, 2016
    Publication date: February 9, 2017
    Applicant: Monsanto Technology LLC
    Inventors: James A. Baum, Allen T. Christian, Artem Evdokimov, Farhad Moshiri, Lisa Marie Weaver, Haitao Zhang
  • Patent number: 9445603
    Abstract: Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: September 20, 2016
    Assignee: Monsanto Technology LLC
    Inventors: James A. Baum, Allen T. Christian, Artem Evdokimov, Farhad Moshiri, Lisa Marie Weaver, Haitao Zhang
  • Publication number: 20160145630
    Abstract: Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis.
    Type: Application
    Filed: March 13, 2014
    Publication date: May 26, 2016
    Applicant: Monsanto Technology LLC
    Inventors: James A. Baum, Allen T. Christian, Artem Evdokimov, Farhad Moshiri, Lisa Marie Weaver, Haitao Zhang
  • Publication number: 20140271559
    Abstract: Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis.
    Type: Application
    Filed: March 13, 2014
    Publication date: September 18, 2014
    Applicant: Monsanto Technology LLC
    Inventors: James A. Baum, Allen T. Christian, Artem Evdokimov, Farhad Moshiri, Lisa Marie Weaver, Haitao Zhang
  • Publication number: 20130067618
    Abstract: The present invention provides novel compositions for use to enhance weed control. Specifically, the present invention provides for methods and compositions that modulate acetolactate synthase in weed species. The present invention also provides for combinations of compositions and methods that enhance weed control.
    Type: Application
    Filed: September 13, 2012
    Publication date: March 14, 2013
    Inventors: DANIEL ADER, John J. Finnessy, Zhaolong Li, Christina Marie Taylor, Jennifer Chou Taylor, Ronak Hasmukh Shah, Nengbing Tao, Dafu Wang, Lisa Marie Weaver